Fact CheckerSign in

NCT04760496CompletedPhase 4

Effect of Increased Oxytocin Doses on the Mode of Delivery in Obese Primiparous Women With Spontaneous or Induced Labour

Effect of Increased Oxytocin Doses on the Mode of Delivery in Obese Primiparous Women With Spontaneous or Induced Labour. A Double-blind, Randomised, Controlled Trial

Source: ClinicalTrials.gov · Last updated 26 Dec 2025

Brief summary (registry, in English)

The rate of caesarean section is higher among obese pregnant women, leading to increased morbidity in this already vulnerable population. Oxytocin is the main drug used in obstetrics to optimize progress of labour, but observational studies have suggested that its efficiency may be insufficient in obese women with usual doses. We design a randomised controlled trial to test the effect of an increased oxytocin dose on the rate of caesarean section in obese primiparous women with spontaneous or induced labour.

Status (registry)
Completed
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
443 (actual)
First submitted
29 Jan 2021
Start date
2 Oct 2021
Primary completion date
30 Dec 2024
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Diseases
Obesity
NCT number
NCT04760496

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 443
  • From 2 Oct 2021 to the primary completion date, 30 Dec 2024
  • 12 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patient with a disease requiring caesarean section prior to labour (planned caesarean section before labour)

Other illness

  • Hypersensitivity to the active substance (oxytocin), to any of its excipients or to latex (risk of cross allergy)
  • Coagulation disorders
  • Foetal heart rate anomalies before use of oxytocin (at the time of inclusion)
  • History of uterine surgery (scarred uterus of gynaecological origin)
  • Severe renal failure

Other

  • Medical contraindication for oxytocin
  • Foetal growth restriction (inferior to 5th percentile)
  • Foetal malformation (major)
  • Patient deprived of their liberty (under curatorship or guardianship)
  • Participation in another interventional trial of category 1. Patients included in interventional research with minimal risk and constraints may participate in the study after the investigator's assessment.

Who the study is looking for

  • Age ≥ 18 years
  • Nulliparous (no previous childbirth beyond 22 SA)
  • BMI ≥ 30 kg/m² at the beginning of pregnancy
  • Singleton pregnancy
  • Spontaneous or induced onset of labour
  • Cephalic presentation
  • Term ≥ 37 weeks of gestation and \< 42 weeks of gestation
  • Medical Indication and absence of medical contraindication for oxytocin during labour: inadequate and/or ineffective uterine contraction and/or delayed cervical dilation
  • Written consent
  • Affiliation to a french social security system

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (12)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU d Angers
Coordinator of this site? Confirm its status
AngersFranceUnknown status
CHU de Bordeaux - Pellegrin
Coordinator of this site? Confirm its status
BordeauxFranceUnknown status
Hôpital Béclère
Coordinator of this site? Confirm its status
ClamartFranceUnknown status
Hopital Bicetre
Coordinator of this site? Confirm its status
Le Kremlin-BicêtreFranceUnknown status
CHU de Montpellier
Coordinator of this site? Confirm its status
MontpellierFranceUnknown status
CHU de Nîmes
Coordinator of this site? Confirm its status
NîmesFranceUnknown status
Hôpital Tenon
Coordinator of this site? Confirm its status
ParisFranceUnknown status
Hopital Cochin - Port Royal
Coordinator of this site? Confirm its status
PARISFranceUnknown status
CHU de Poissy St Germain
Coordinator of this site? Confirm its status
PoissyFranceUnknown status
Chu de Saint Etienne
Coordinator of this site? Confirm its status
Saint-EtienneFranceUnknown status
CHU de Strasbourg (Centre Médico Chirurgical et Obstétrical)
Coordinator of this site? Confirm its status
SchiltigheimFranceUnknown status
CHU de Strasbourg Hôpital de Hautepierre
Coordinator of this site? Confirm its status
StrasbourgFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.